2cureX AB Company Description

2cureX AB (publ) operates as a medtech company in Europe.

The company’s principal product is IndiTreat, an IVD test, which helps to predict cancer patient’s response and resistance to different drugs and select the appropriate treatment.

It is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers.

In addition, the company offers research and consulting services. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.

2cureX AB (publ)

Country	Sweden
Founded	2006
Industry	Electromedical and Electrotherapeutic Apparatus
Employees	14
CEO	Nathaniel Hutley

Contact Details

Address: Fruebjergvej 3 Copenhagen, 2100 Denmark
Phone	45 22 11 53 99
Website	2curex.com

Stock Details

Ticker Symbol	2QE
Exchange	Frankfurt Stock Exchange
Fiscal Year	January - December
Reporting Currency	SEK
SIC Code	3845

Key Executives

Name	Position
Nathaniel Hutley	Chief Executive Officer
Kenneth Johansen	Chief Financial Officer